Article
MiRNA as a Potential Target for Multiple Myeloma Therapy–Current Knowledge and Perspectives
31 Aug 2022
Abstract excerpt
Multiple myeloma (MM) is the second most common hematological malignancy. Despite the huge therapeutic progress thanks to the introduction of novel therapies, MM remains an incurable disease. Extensive research is currently ongoing to find new options. MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression at a post-transcriptional level. Aberrant expression of miRNAs in MM is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
